Prashoban Bremjit, MD
Orthopaedic Surgery · Renton, WANPI 1699162289
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 31.4% of the total. 2025 is the largest year on record at $10,712, 2.7 times the $4,036 reported in 2020.
Across 95 payments — averaging $304.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$9K
- Smith+Nephew$8K
- Johnson & Johnson$3K
- Medacta USA, Inc.$2K
- Zimmer Biomet$2K
- Orthalign Inc$2K
- plus $4K from 4 others
What the payments were for
- Consulting fees$8,96031%
- Speaking & faculty fees$1,5005%
- Travel & lodging$6,44922%
- Food & beverage$4,44615%
- Education$7,55526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 6 | $9,091 |
| Smith+Nephew | 8 | $7,932 |
| Johnson & Johnson | 11 | $2,538 |
| Medacta USA, Inc. | 19 | $2,444 |
| Zimmer Biomet | 24 | $1,708 |
| Orthalign Inc | 8 | $1,593 |
| Encore Medical, LP | 2 | $1,569 |
| Medical Device Business Services, Inc. | 8 | $1,541 |
| Stryker | 7 | $354 |
| Medtronic | 2 | $139 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHALIGN PLUS$1,536
- DJO Surgical Exprt Revision Knee$1,500
- DJO Surgical Empowr Knee System$1,500
- DJO Surgical TaperFill Hip System$1,500
- AMIStem H Femoral Stems$1,355
- Velys$1,236
- GMK Sphere Revision System$569
- Avenir$445
- ROSA$385
- Persona$149
- REAL INTELLIGENCE$142
- JOURNEY II UK$133
- Legion Revision$133
- Journey II BCS$133
- MAKO$127
- AQUAMANTYS$118
- MYKNEE$117
- ATTUNE$113
How this compares
$28,909 in reported general payments places this provider in the 85th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 141 | $1,016 |
| Meloxicam | 71 | $405 |
| Diclofenac Sodium | 12 | $377 |
| Hydromorphone Hcl | 17 | $130 |
| Amoxicillin | 68 | $89 |
| Tramadol Hcl | 16 | $39 |
| Clindamycin Hcl | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Renton
- William BarrettRenton$7.7M
- Timothy AltonRenton$1.5M
- Andrew MerrittRenton$59K
- William HannayRenton$37K
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Burt YaszaySeattle$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.